|
Address:
|
3410 Central Expressway
Santa Clara, CA 95051
United States
|
|
Phone:
|
1-408-616-7200
|
|
Url: |
http://www.xenoport.com/
|
|
Type:
|
Public
|
|
Industry:
|
Pharmaceuticals Manufacturers
|
|
Employees:
|
120
|
|
Description:
|
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. The Company's most advanced product candidate has completed two Phase II clinical trials for the treatment of restless legs syndrome (RLS), and is being evaluated in a Phase III clinical program for this indication. This product candidate has also completed a Phase IIa clinical trial for the management of post-herpetic neuralgia (PHN). Its second product candidate has generated positive preliminary data in a Phase IIa clinical trial for reducing the number of reflux episodes in patients with gastroesophageal reflux disease (GERD). For the three months ended 31 March 2006, Xenoport, Inc.'s revenues fell 54% to $1.3M. Net loss applicable to Common rose 46% to $15M. Revenues reflect the conclusion of the ALZA collaboration and the absence of grant revenue. Higher loss reflects an increase in research & development expenses and higher general & administrative expenses due to increased development activities. XenoPort, Inc. is biopharmaceutical company focused on developing products.
|
Available Positions
We are looking for a talented scientist with broad experience in animal neuropharmacology models to join our discovery research group in this newly created position. This person will work closely with members of the discovery biology and medicinal chemistry groups to evaluate novel drug candidates for specific CNS targets.
Responsibilities include
* assessment of appropriate animal models for eac
We are current looking for an energetic and talented Analytical Chemist to join our Analytical Development group within Pharmaceutical Operations. The group is well equipped with advanced analytical instrumentation and techniques, such as HPLC, IC, dissolution apparatus, particle size analyzer, LC/MS/MS, GC/MS, NMR, as well as state-of-the-art data processing and management systems. This position
We are currently seeking an experienced pharmaceutical industry physician to become a member of our growing Clinical organization. This position will be involved primarily in Phase 2 and 3 studies of a transported prodrug of baclofen for treatment of symptomatic GERD (gastroesophogeal reflux disease.) This position will provide leadership and direction to the clinical team specializing in gastroin
|
How would you rate XenoPort, Inc.?
Be the first to rate this company!
|
